This website is intended for healthcare professionals only.

Hospital Pharmacy Europe     Newsletter          

Oncology

Prostate cancer screening with MRI after PSA a cost-effective strategy
Prostate cancer screening with MRI after PSA a cost-effective strategy
Read more
Study suggests thyroid cancer increases coronary heart disease risk
Study suggests thyroid cancer increases coronary heart disease risk
Read more
Polygenic risk score and family history combined improve prostate cancer risk stratification
Polygenic risk score and family history combined improve prostate cancer risk stratification
Read more
Deep learning algorithm outperforms radiologists in detecting head and neck cancer spread
Deep learning algorithm outperforms radiologists in detecting head and neck cancer spread
Read more
Daily steps AI model predicts unplanned hospitalisation during chemo-radiation
Daily steps AI model predicts unplanned hospitalisation during chemo-radiation
Read more
Aspirin use in residual breast cancer disease improves distant metastases free survival 
Aspirin use in residual breast cancer disease improves distant metastases free survival 
Read more
Atezolizumab anti-drug antibodies worsen survival in hepatocellular carcinoma
Atezolizumab anti-drug antibodies worsen survival in hepatocellular carcinoma
Read more
Invitations for screening colonoscopy reduces risk of colorectal cancer
Invitations for screening colonoscopy reduces risk of colorectal cancer
Read more
Meet the Expert: Irma Verdonck-de Leeuw
Meet the Expert: Irma Verdonck-de Leeuw
Read more
Prenatal high-dose folic acid linked to increased childhood cancer risk
Prenatal high-dose folic acid linked to increased childhood cancer risk
Read more
Neoadjuvant therapy produces almost complete response in dMMR colon cancer
Neoadjuvant therapy produces almost complete response in dMMR colon cancer
Read more
RP2 oncolytic HSV therapy shows promise in advanced cancer
RP2 oncolytic HSV therapy shows promise in advanced cancer
Read more
Tumour-infiltrating lymphocyte therapy superior to ipilimumab in advanced melanoma
Tumour-infiltrating lymphocyte therapy superior to ipilimumab in advanced melanoma
Read more
Caffeine genotype linked to better prostate cancer survival
Caffeine genotype linked to better prostate cancer survival
Read more
Particulate matter in air pollution may cause lung cancer in never smokers
Particulate matter in air pollution may cause lung cancer in never smokers
Read more
Sotorasib and panitumumab effective in treatment-resistant metastatic colorectal cancer
Sotorasib and panitumumab effective in treatment-resistant metastatic colorectal cancer
Read more
Low vitamin D levels linked to worse overall survival in invasive melanoma
Low vitamin D levels linked to worse overall survival in invasive melanoma
Read more

Popular articles

Novel extracorporeal liver device deemed safe and effective in severe liver failure
Two-thirds of patients correctly diagnosed with promising cancer blood test
Are anti-diabetic drugs the silver bullet for the obesity epidemic?





 

Download Hospital Healthcare Europe free app

Download our app from the Apple App Store Download our app from Google Play

In official association with

HOPE Logo Footer

© Cogora 2023
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora